Search

Your search keyword '"Didier Hannequin"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Didier Hannequin" Remove constraint Author: "Didier Hannequin" Language english Remove constraint Language: english
83 results on '"Didier Hannequin"'

Search Results

1. Phenotype and imaging features associated with APP duplications

2. Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies

3. How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years

4. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

5. An Autopsy Case of Amyotrophic Lateral Sclerosis with Waldenström Macroglobulinemia and Anti-MAG Gammopathy

6. Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease

7. Association study of the GAB2 gene with the risk of developing Alzheimer's disease

8. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

9. Visual agnosia and posterior cerebral artery infarcts: an anatomical-clinical study.

10. New insights into the genetic etiology of Alzheimer's disease and related dementias

11. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

12. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial

13. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers

14. Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial

15. Primary Progressive Aphasia Associated With GRN Mutations: New Insights Into the Nonamyloid Logopenic Variant

16. Correction: Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment

17. Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications

18. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

19. Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment

20. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

21. Neurobiol Aging

22. Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer’s Disease Before 51 Years

23. How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years

24. Neurite density is reduced in the presymptomatic phase of C9orf72 disease

25. What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France

26. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

27. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP

28. Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia: An MRI Study of 16 French Cases

29. Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease

30. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers

31. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

32. Analysis of shared heritability in common disorders of the brain

33. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment*

34. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

35. 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression

36. Contribution to Alzheimer's disease risk of rare variants in TREM_2, SORL_1, and ABCA_7 in 1779 cases and 1273 controls

37. Seizures in dominantly inherited Alzheimer disease

38. Identification of partial SLC20A2 deletions in primary brain calcification using whole-exome sequencing

39. Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons

40. Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations

41. Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study

42. Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?

43. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export

44. Mutation in the 3’untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy

45. Multimodal neuroimaging study in presymptomatic GRN mutations carriers

46. hnRNPA2B1 and hnRNPA1 mutations are rare in patients with 'multisystem proteinopathy' and frontotemporal lobar degeneration phenotypes

47. A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia

48. Frontotemporal dementia and its subtypes: A genome-wide association study

49. PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum

50. Just do it! How performing an action enhances remembering in transient global amnesia

Catalog

Books, media, physical & digital resources